Optimization of Absolute Coronary Blood Flow Measurements to Assess Microvascular Function: In Vivo Validation of Hyperemia and Higher Infusion Speeds.

IF 6.1 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Circulation: Cardiovascular Interventions Pub Date : 2024-07-01 Epub Date: 2024-04-29 DOI:10.1161/CIRCINTERVENTIONS.123.013860
Lennert Minten, Johan Bennett, Keir McCutcheon, Wouter Oosterlinck, Michiel Algoet, Hisao Otsuki, Kuniaki Takahashi, William F Fearon, Christophe Dubois
{"title":"Optimization of Absolute Coronary Blood Flow Measurements to Assess Microvascular Function: In Vivo Validation of Hyperemia and Higher Infusion Speeds.","authors":"Lennert Minten, Johan Bennett, Keir McCutcheon, Wouter Oosterlinck, Michiel Algoet, Hisao Otsuki, Kuniaki Takahashi, William F Fearon, Christophe Dubois","doi":"10.1161/CIRCINTERVENTIONS.123.013860","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reliable assessment of coronary microvascular function is essential. Techniques to measure absolute coronary blood flow are promising but need validation. The objectives of this study were: first, to validate the potential of saline infusion to generate maximum hyperemia in vivo. Second, to validate absolute coronary blood flow measured with continuous coronary thermodilution at high (40-50 mL/min) infusion speeds and asses its safety.</p><p><strong>Methods: </strong>Fourteen closed-chest sheep underwent absolute coronary blood flow measurements with increasing saline infusion speeds at different dosages under general anesthesia. An additional 7 open-chest sheep underwent these measurements with epicardial Doppler flow probes. Coronary flows were compared with reactive hyperemia after 45 s of coronary occlusion.</p><p><strong>Results: </strong>Twenty milliliters per minute of saline infusion induced a significantly lower hyperemic coronary flow (140 versus 191 mL/min; <i>P</i>=0.0165), lower coronary flow reserve (1.82 versus 3.21; <i>P</i>≤0.0001), and higher coronary resistance (655 versus 422 woods units; <i>P</i>=0.0053) than coronary occlusion. On the other hand, 30 mL/min of saline infusion resulted in hyperemic coronary flow (196 versus 192 mL/min; <i>P</i>=0.8292), coronary flow reserve (2.77 versus 3.21; <i>P</i>=0.1107), and coronary resistance (415 versus 422 woods units; <i>P</i>=0.9181) that were not different from coronary occlusion. Hyperemic coronary flow was 40.7% with 5 mL/min, 40.8% with 10 mL/min, 73.1% with 20 mL/min, 102.3% with 30 mL/min, 99.0% with 40 mL/min, and 98.0% with 50 mL/min of saline infusion when compared with postocclusive hyperemic flow. There was a significant bias toward flow overestimation (Bland-Altman: bias±SD, -73.09±30.52; 95% limits of agreement, -132.9 to -13.27) with 40 to 50 mL/min of saline. Occasionally, ischemic changes resulted in ventricular fibrillation (9.5% with 50 mL/min) at higher infusion rates.</p><p><strong>Conclusions: </strong>Continuous saline infusion of 30 mL/min but not 20 mL/min induced maximal hyperemia. Absolute coronary blood flow measured with saline infusion speeds of 40 to 50 mL/min was not accurate and not safe.</p>","PeriodicalId":10330,"journal":{"name":"Circulation: Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":6.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Cardiovascular Interventions","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCINTERVENTIONS.123.013860","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Reliable assessment of coronary microvascular function is essential. Techniques to measure absolute coronary blood flow are promising but need validation. The objectives of this study were: first, to validate the potential of saline infusion to generate maximum hyperemia in vivo. Second, to validate absolute coronary blood flow measured with continuous coronary thermodilution at high (40-50 mL/min) infusion speeds and asses its safety.

Methods: Fourteen closed-chest sheep underwent absolute coronary blood flow measurements with increasing saline infusion speeds at different dosages under general anesthesia. An additional 7 open-chest sheep underwent these measurements with epicardial Doppler flow probes. Coronary flows were compared with reactive hyperemia after 45 s of coronary occlusion.

Results: Twenty milliliters per minute of saline infusion induced a significantly lower hyperemic coronary flow (140 versus 191 mL/min; P=0.0165), lower coronary flow reserve (1.82 versus 3.21; P≤0.0001), and higher coronary resistance (655 versus 422 woods units; P=0.0053) than coronary occlusion. On the other hand, 30 mL/min of saline infusion resulted in hyperemic coronary flow (196 versus 192 mL/min; P=0.8292), coronary flow reserve (2.77 versus 3.21; P=0.1107), and coronary resistance (415 versus 422 woods units; P=0.9181) that were not different from coronary occlusion. Hyperemic coronary flow was 40.7% with 5 mL/min, 40.8% with 10 mL/min, 73.1% with 20 mL/min, 102.3% with 30 mL/min, 99.0% with 40 mL/min, and 98.0% with 50 mL/min of saline infusion when compared with postocclusive hyperemic flow. There was a significant bias toward flow overestimation (Bland-Altman: bias±SD, -73.09±30.52; 95% limits of agreement, -132.9 to -13.27) with 40 to 50 mL/min of saline. Occasionally, ischemic changes resulted in ventricular fibrillation (9.5% with 50 mL/min) at higher infusion rates.

Conclusions: Continuous saline infusion of 30 mL/min but not 20 mL/min induced maximal hyperemia. Absolute coronary blood flow measured with saline infusion speeds of 40 to 50 mL/min was not accurate and not safe.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
优化绝对冠状动脉血流量测量以评估微血管功能:高血流量和更高输注速度的体内验证。
背景:对冠状动脉微血管功能进行可靠的评估至关重要。测量冠状动脉绝对血流量的技术很有前景,但需要验证。本研究的目的是:首先,验证生理盐水输注在体内产生最大充血的潜力。其次,验证连续冠状动脉热稀释法在高速(40-50 毫升/分钟)输注下测量的绝对冠状动脉血流量,并评估其安全性:方法:14 只闭胸绵羊在全身麻醉的情况下,以不同剂量的生理盐水输注速度进行了绝对冠状动脉血流量测量。另外 7 只开胸绵羊使用心外膜多普勒血流探头进行了测量。冠状动脉血流与冠状动脉闭塞 45 秒后的反应性充血进行了比较:结果:与冠状动脉闭塞相比,每分钟 20 毫升生理盐水输注诱导的充血冠状动脉血流量(140 对 191 毫升/分钟;P=0.0165)、冠状动脉血流储备(1.82 对 3.21;P≤0.0001)和冠状动脉阻力(655 对 422 林单位;P=0.0053)均显著降低。另一方面,30 毫升/分钟的生理盐水输注导致的充盈冠状动脉血流(196 对 192 毫升/分钟;P=0.8292)、冠状动脉血流储备(2.77 对 3.21;P=0.1107)和冠状动脉阻力(415 对 422 伍兹单位;P=0.9181)与冠状动脉闭塞没有区别。与闭塞后高血流相比,5 毫升/分钟的高血流冠脉流量为 40.7%,10 毫升/分钟为 40.8%,20 毫升/分钟为 73.1%,30 毫升/分钟为 102.3%,40 毫升/分钟为 99.0%,50 毫升/分钟为 98.0%。生理盐水浓度为 40 至 50 毫升/分钟时,存在明显的血流高估偏差(Bland-Altman:偏差±SD,-73.09±30.52;95% 一致度,-132.9 至-13.27)。在较高的输注速度下,缺血性变化偶尔会导致心室颤动(50 毫升/分钟时为 9.5%):结论:生理盐水持续输注 30 毫升/分钟可诱导最大充血,20 毫升/分钟则不能。用 40 至 50 毫升/分钟的生理盐水输注速度测量的绝对冠状动脉血流量既不准确也不安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Circulation: Cardiovascular Interventions
Circulation: Cardiovascular Interventions CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
10.30
自引率
1.80%
发文量
221
审稿时长
6-12 weeks
期刊介绍: Circulation: Cardiovascular Interventions, an American Heart Association journal, focuses on interventional techniques pertaining to coronary artery disease, structural heart disease, and vascular disease, with priority placed on original research and on randomized trials and large registry studies. In addition, pharmacological, diagnostic, and pathophysiological aspects of interventional cardiology are given special attention in this online-only journal.
期刊最新文献
Enhancing Coronary Revascularization Decisions: The Promising Role of Large Language Models as a Decision-Support Tool for Multidisciplinary Heart Team. Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy. Large Language Models and Revascularization Decisions: The Newest Member of Your Multidisciplinary Heart Team? Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial. Transcatheter Mitral Valve Replacement Using Annular Reduction by Cinching With TEER in the Commissure (ARCTIC).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1